Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.
NCT ID: NCT06122220
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2025-08-15
2026-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the present study is to correlate the measurement of ONSD with serum angiogenic factor (AF) values in patients with pre-eclampsia and to determine its predictive ability for adverse perinatal outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.
NCT05594056
Angiogenic Factors in the Conservative Management of Gestational Hypertension
NCT06123377
Cardiovascular Risk After Preeclampsia
NCT05277233
Assessment of Optic Nerve Sheath Diameter in Preeclamptic Pregnant Women Using Ultrasonography and Anesthetic Management
NCT06522295
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
NCT06403722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-eclampsia
Subjects admitted with severe pre-eclampsia, based on the criteria by the American College of Obstetricians and Gynecologists (ACOG)
ONSD+AF
Measurement of the optic nerve sheath diameter and of sFLT-1/PGIF index
Control
Subjects admitted for normal labor, without any criteria of pre-eclampsia
ONSD+AF
Measurement of the optic nerve sheath diameter and of sFLT-1/PGIF index
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ONSD+AF
Measurement of the optic nerve sheath diameter and of sFLT-1/PGIF index
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Maternal vasculitis
* Previous cesarean section (3 or more)
* Brain or eye tumors
* Neurological conditions
* Chronic renal disease
* Purpura
* Heart disease
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint Thomas Hospital, Panama
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osvaldo A. Reyes T.
Head of the research deparment
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Thomas Hospital
Panama City, Provincia de Panamá, Panama
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FA012023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.